Community Research and Development Information Service - CORDIS

ERC

GlycoTarget Report Summary

Project ID: 616966
Funded under: FP7-IDEAS-ERC
Country: Belgium

Mid-Term Report Summary - GLYCOTARGET (Exploring the targeted delivery of biopharmaceuticals enabled by glycosylation control.)

The GlycoTarget project aims at investigating the use of glycosylation engineering for enhancing the properties of biopharmaceuticals. The target areas are liver disease, allergy and tuberculosis infection. This project is now mid-way and has resulted in novel glycoprotein production methodologies (GlycoDelete) as well as novel biopharmaceutical candidate molecules in the three target areas. In the remainder of the grant runtime, these candidate molecules will be fully explored for their therapeutic potential and the mechanism of their action.

Contact

Rik Audenaert, (Managing Director)
Tel.: +32 92446611
Fax: +32 92446610
E-mail
Record Number: 193271 / Last updated on: 2017-01-17
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top